| First Author | Eso Y | Year | 2016 |
| Journal | Cancer Res | Volume | 76 |
| Issue | 15 | Pages | 4383-93 |
| PubMed ID | 27261510 | Mgi Jnum | J:234841 |
| Mgi Id | MGI:5791000 | Doi | 10.1158/0008-5472.CAN-15-2926 |
| Citation | Eso Y, et al. (2016) MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development. Cancer Res 76(15):4383-93 |
| abstractText | Inflammation predisposes to tumorigenesis in various organs by potentiating a susceptibility to genetic aberrations. The mechanism underlying the enhanced genetic instability through chronic inflammation, however, is not clear. Here, we demonstrated that TNFalpha stimulation induced transcriptional downregulation of MSH2, a member of the mismatch repair family, via NF-kappaB-dependent miR-21 expression in hepatocytes. Liver cancers developed in ALB-MSH2(-) (/) (-)AID(+), ALB-MSH2(-) (/) (-), and ALB-AID(+) mice, in which MSH2 is deficient and/or activation-induced cytidine deaminase (AICDA) is expressed in cells with albumin-producing hepatocytes. The mutation signatures in the tumors developed in these models, especially ALB-MSH2(-) (/) (-)AID(+) mice, closely resembled those of human hepatocellular carcinoma. Our findings demonstrated that inflammation-mediated dysregulation of MSH2 may be a mechanism of genetic alterations during hepatocarcinogenesis. Cancer Res; 76(15); 4383-93. (c)2016 AACR. |
